Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China flag China · Delayed Price · Currency is CNY
65.30
+5.18 (8.62%)
Apr 29, 2026, 3:00 PM CST

SHA:603538 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
490.82701.67585.43456.04791.94421.79
Trading Asset Securities
150.7216.82154.44268.65217.38371.38
Cash & Short-Term Investments
641.51918.49739.87724.691,009793.16
Cash Growth
-5.64%24.14%2.09%-28.20%27.25%88.83%
Accounts Receivable
335.01378.94331.32320.73187.59222.73
Other Receivables
31.9926.3952.8260.4528.4516.53
Receivables
367405.33384.14381.19216.04239.26
Inventory
920.8858.72773.76612.6594.42579.69
Prepaid Expenses
--0.18---
Other Current Assets
120.48102.2273.540.974.6190.29
Total Current Assets
2,0502,2851,9711,7591,8941,702
Property, Plant & Equipment
1,7881,8321,8881,9001,8021,615
Long-Term Investments
384.45384.42327.4315.32300.11319.59
Goodwill
-----22.74
Other Intangible Assets
195.59191.5203.4166.23142.73181.92
Long-Term Deferred Tax Assets
49.3437.9941.1642.67123.1833.27
Long-Term Deferred Charges
53.0252.8944.1155.2450.1641.09
Other Long-Term Assets
77.4568.5175.59184.34107.0185.81
Total Assets
4,5984,8524,6514,4244,4194,001
Accounts Payable
459.67511.51508.18390.99345.45220.92
Accrued Expenses
28.1649.2161.1561.7155.9850.62
Short-Term Debt
601.27697.48479.06486.72465.28425.87
Current Portion of Long-Term Debt
149.62115.53195.5453.8328.4475.65
Current Portion of Leases
--2.972.263.293.52
Current Income Taxes Payable
19.5415.930.095.3656.9225.83
Current Unearned Revenue
103.13145.49148.88153.09194.9281.06
Other Current Liabilities
53.1349.12190.11224.31211.94263.36
Total Current Liabilities
1,4151,5841,5861,3781,3621,147
Long-Term Debt
544.11678.59651.62743.96675.25727.31
Long-Term Leases
11.811.1512.3515.6930.3428.03
Long-Term Unearned Revenue
95.4495.2683.1881.4870.5748.67
Long-Term Deferred Tax Liabilities
33.2427.4921.8213.59103.1267.31
Other Long-Term Liabilities
4.764.764.854.854.854.85
Total Liabilities
2,1042,4022,3602,2382,2462,023
Common Stock
220.49220.63218.75213.41213.38151.32
Additional Paid-In Capital
675.22665.47632.47583.45561.87587.21
Retained Earnings
1,4321,4011,3091,2471,271962.13
Treasury Stock
-28.92-28.92-45.67-23.08-31.99-27.97
Comprehensive Income & Other
78.7677.9877.8975.5971.1278.8
Total Common Equity
2,3772,3362,1932,0962,0851,751
Minority Interest
116.61115.1798.789.4388.25227.02
Shareholders' Equity
2,4942,4512,2912,1862,1731,979
Total Liabilities & Equity
4,5984,8524,6514,4244,4194,001
Total Debt
1,3071,5031,3421,3021,2031,260
Net Cash (Debt)
-665.29-584.26-601.66-577.77-193.29-467.21
Net Cash Per Share
-2.96-2.69-2.79-2.49-0.85-2.20
Filing Date Shares Outstanding
222.59182.66218.75213.41213.38211.39
Total Common Shares Outstanding
222.59182.66218.75213.41213.38211.39
Working Capital
635.28700.5385.49381.11532.16555.58
Book Value Per Share
10.6812.7910.029.829.778.29
Tangible Book Value
2,1822,1441,9891,9301,9421,547
Tangible Book Value Per Share
9.8011.749.099.049.107.32
Buildings
--872.69697.36593.92513.49
Machinery
--1,2301,0871,054817.08
Construction In Progress
--358.36576.39502.88733.82
Source: S&P Global Market Intelligence. Standard template. Financial Sources.